Literature DB >> 7720473

Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis.

L Cicalese1, R H Duerr, M A Nalesnik, P F Heeckt, K K Lee, W H Schraut.   

Abstract

Patients with chronic ulcerative colitis (CUC) are known to have decreased spontaneous IgA secretion by colonic mononuclear cells. The aim of this study was to determine whether a similar alteration exists in the apparently healthy ileum of patients with CUC. The concentration of IgA was measured in the supernatant from homogenized mucosal ileal biopsies using a sandwich-type ELISA. The concentration of IgA was significantly (P = 0.025) decreased in the ileum of patients with CUC (N = 24) in comparison to normal ileum (N = 10). The number of mucosal IgA-containing mononuclear cells (MNC) was also determined using an avidin-biotin-immunoperoxidase technique on paraffin-embedded ileal sections. Although reduced, the number of positive cells and their distribution was not significantly different in the ileum of patients with CUC (N = 20) when compared to normal ileum (N = 10). We suggest that decreased mucosal IgA levels are a panintestinal condition in CUC and that this is a primary alteration rather than a secondary response to the inflammatory process. Considering the role of IgA, we propose that decreased mucosal IgA levels in CUC may predispose to the disease by a reduction of the immune-mediated exclusion mechanism and/or by an impairment of the down-regulation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720473     DOI: 10.1007/bf02064983

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA.

Authors:  M W Russell; B Mansa
Journal:  Scand J Immunol       Date:  1989-08       Impact factor: 3.487

2.  Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.

Authors:  J F Engstrom; C Arvanitakis; A Sagawa; N I Abdou
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

3.  Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.

Authors:  J R Cangemi; R H Wiesner; S J Beaver; J Ludwig; R L MacCarty; R R Dozois; A R Zinsmeister; N F LaRusso
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 4.  Cellular aspects of immunoglobulin A.

Authors:  M E Lamm
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

5.  Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs.

Authors:  R P MacDermott; M G Beale; C D Alley; G S Nash; M J Bertovich; M J Bragdon
Journal:  Ann N Y Acad Sci       Date:  1983-06-30       Impact factor: 5.691

Review 6.  Structure and function of intestinal mucin: developmental aspects.

Authors:  J D Snyder; W A Walker
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

7.  Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis.

Authors:  A H Kartheuser; R R Dozois; R H Wiesner; N F LaRusso; D M Ilstrup; C D Schleck
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

8.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.

Authors:  J H Helzberg; J M Petersen; J L Boyer
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

9.  Bacterial overgrowth after high-dose corticosteroid treatment.

Authors:  H Denison; S Wallerstedt
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

10.  Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease.

Authors:  R P MacDermott; G S Nash; M J Bertovich; R F Mohrman; I J Kodner; D L Delacroix; J P Vaerman
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

View more
  3 in total

Review 1.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ.

Authors:  Y Z Almallah; S W Ewen; A El-Tahir; N A Mowat; P W Brunt; T S Sinclair; S D Heys; O Eremin
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

3.  The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it.

Authors:  Liljana Stevceva; Paul Pavli; Alan J Husband; William F Doe
Journal:  BMC Clin Pathol       Date:  2001
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.